, Columnist
Biopharma's Trump Party Is a Little Too Raucous
Policy uncertainty and pricing pressure haven't gone away.
This article is for subscribers only.
It's November 9, and this guy is set to be America's 45th President. Americans are split between cheering and Googling Canadian citizenship requirements. Pharma and biotech currently seem to be on the whooping-with-joy side.
The Nasdaq Biotech Index gained 7.5 percent on the Wednesday after Election Day -- its biggest jump since 2008 -- and big-pharma bellwether Pfizer rose 8 percent.